GGrantIndex
Sort

51,593 grants matching hepatitis

Mechanism of Hepatitis E Virus Replication and Pathogenesis

$378,350
Xiang-Jin Meng · Virginia Polytechnic Inst And St Univ · R01 · FY2013 · AI

BARTONELLA--A MODEL FOR AN AIDS OPPORTUNISTIC PATHOGEN

$378,344
University Of California San Francisco · R01 · FY2000 · AI

Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis

$378,324
Natalia Nieto · Icahn School Of Medicine At Mount Sinai · U01 · FY2013 · AA

Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer

$378,315
Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2023 · CA

Inherited Variations in Drug Metabolizing Enzymes

$378,312
Richard M Weinshilboum · Mayo Clinic Rochester · R01 · FY2009 · GM

CYTOCHROME P450--ENDOGENOUS SUBSTRATE METABOLISM

$378,307
Boston University · R01 · FY2002 · DK

Community Outreach and Engagement

$378,301
Moon S Chen · University Of California At Davis · P30 · FY2023 · CA

Molecular Mechanisms of Rapamycin's effects on Health and longevity.

$378,287
Joseph A. Baur · University Of Pennsylvania · R01 · FY2017 · AG

HBV-Ethanol Interactions in Liver Disease

$378,250
Thomas Jefferson University · R01 · FY2003 · AA

Molecular Approaches To Vaccine Development For Hepatitis C

$378,243
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence

$378,243
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy

$378,243
Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

The Genetics of Disease Progression and Treatment Response in Hepatitis C

$378,243
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

Modulation of Acute Liver Injury

$378,223
Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2013 · DK

Targeting the liver for immunotherapy in pancreatic cancer

$378,219
Gregory L Beatty · University Of Pennsylvania · R01 · FY2023 · CA

Imaging Liver Cancer Proliferation

$378,195
Zhenghong Lee · Case Western Reserve University · R01 · FY2018 · CA

Novel Pharmacological Strategies for Liver Disease in Antitrypsin Deficiency

$378,194
David H Perlmutter · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DK

Regulation of B cells in the CNS

$378,154
Cornelia C Bergmann · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · NS

Helicase Regulation of dsRNA Signaling and Innate Antiviral Immune Responses

$378,146
Curt M Horvath · Northwestern University · R01 · FY2011 · AI

Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands

$378,125
Ravikumar N Majeti · Texas A&M University · R01 · FY2020 · DK

Single-molecule and super-resolution studies of RIG-I pathways

$378,118
Taekjip Ha · University Of Southern California · U19 · FY2010 · AI

Metabolism and Genetics of Hypobetalipoproteinemia

$378,101
Washington University · R01 · FY2004 · HL

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C

$378,094
Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK

Post-translational regulation of hepatic uptake transporters in health and disease

$378,081
Bruno Hagenbuch · University Of Kansas Medical Center · R01 · FY2025 · GM

Biological Markers of Aflatoxin Exposure

$378,073
Columbia University Health Sciences · R01 · FY2005 · ES